1. Marshall BJ, Warren JR (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1: 1311-1315.
2. Goodwin CS, McCulloch RK, Armstrong JA, Wee SH (1985) Unusual cellular fatty acids and distinctive ultrastructure in a new spiral bacterium (Campylobacter pyloridis) from the human gastric mucosa. J Med Microbiol 19: 257-267.
3. Goodwin CS, Armstrong JA (1990) Microbiological aspects of Helicobacter pylori (Campylobacter pylori). Eur J Clin Microbiol Infect Dis 9: 1-13.
4. Falush D, Kraft C, Taylor NS, Correa P, Fox JG, et al. (2001) Recombination and mutation during long-term gastric colonization by Helicobacter pylori: estimates of clock rates, recombination size, and minimal age. Proc Natl Acad Sci U S A 98:
15056-15061.
5. Suerbaum S, Smith JM, Bapumia K, Morelli G, Smith NH, et al. (1998) Free recombination within Helicobacter pylori. Proc Natl Acad Sci U S A 95: 12619-12624.
6. Mobley HL, Garner RM, Bauerfeind P (1995) Helicobacter pylori nickel-transport gene nixA: synthesis of catalytically active urease in Escherichia coli independent of growth conditions. Mol Microbiol 16: 97-109.
7. Eaton KA, Brooks CL, Morgan DR, Krakowka S (1991) Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect Immun 59: 2470-2475.
8. Kusters JG, van Vliet AH, Kuipers EJ (2006) Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 19: 449-490.
9. RA F, editor (2001) Epidemiologic observations and open questions about disease and infection caused by Helicobacter pylori. Wymondham, United Kingdom: Horizon Sicentific Press. 29-51 p.
10. Blaser MJ (1987) Gastric Campylobacter-like organisms, gastritis, and peptic ulcer disease. Gastroenterology 93: 371-383.
11. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, et al. (1991) Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:
1127-1131.
12. Forman D, Newell DG, Fullerton F, Yarnell JW, Stacey AR, et al. (1991) Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 302: 1302-1305.
13. Forman D (1991) Helicobacter pylori infection: a novel risk factor in the etiology of gastric cancer. J Natl Cancer Inst 83: 1702-1703.
14. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, et al. (1991)
37
Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 325: 1132-1136.
15. Gerrits MM, van Vliet AH, Kuipers EJ, Kusters JG (2006) Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications. Lancet Infect Dis 6: 699-709.
16. Nishizawa T, Suzuki H, Hibi T (2009) Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication. J Clin Biochem Nutr 44: 119-124.
17. Glocker E, Kist M (2004) Rapid detection of point mutations in the gyrA gene of Helicobacter pylori conferring resistance to ciprofloxacin by a fluorescence resonance energy transfer-based real-time PCR approach. J Clin Microbiol 42: 2241-2246.
18. Cattoir V, Nectoux J, Lascols C, Deforges L, Delchier JC, et al. (2007) Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility. Int J Antimicrob Agents 29: 389-396.
19. Bogaerts P, Berhin C, Nizet H, Glupczynski Y (2006) Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium. Helicobacter 11: 441-445.
20. Cabrita J, Oleastro M, Matos R, Manhente A, Cabral J, et al. (2000) Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999).
J Antimicrob Chemother 46: 1029-1031.
21. Miyachi H, Miki I, Aoyama N, Shirasaka D, Matsumoto Y, et al. (2006) Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan.
Helicobacter 11: 243-249.
22. Kim JM, Kim JS, Kim N, Jung HC, Song IS (2005) Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients. J Antimicrob Chemother 56:
965-967.
23. Hung KH, Sheu BS, Chang WL, Wu HM, Liu CC, et al. (2009) Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern Taiwan. Helicobacter 14: 61-65.
24. Levine C, Hiasa H, Marians KJ (1998) DNA gyrase and topoisomerase IV: biochemical activities, physiological roles during chromosome replication, and drug sensitivities.
Biochim Biophys Acta 1400: 29-43.
25. Mitscher LA (2005) Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents. Chem Rev 105: 559-592.
26. Michael A. Kohanski DJDaJJC (2010) How antibiotics kill bacteria: from targets to networks. Nature Reviews Microbiology 8: 423-435.
27. Tomb JF, White O, Kerlavage AR, Clayton RA, Sutton GG, et al. (1997) The complete
38
genome sequence of the gastric pathogen Helicobacter pylori. Nature 388: 539-547.
28. Reece RJ, Maxwell A (1991) DNA gyrase: structure and function. Crit Rev Biochem Mol Biol 26: 335-375.
29. Matsuzaki J, Suzuki H, Tsugawa H, Nishizawa T, Hibi T (2010) Homology model of the DNA gyrase enzyme of Helicobacter pylori, a target of quinolone-based eradication therapy. J Gastroenterol Hepatol 25 Suppl 1: S7-10.
30. Moore RA, Beckthold B, Wong S, Kureishi A, Bryan LE (1995) Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori. Antimicrob Agents Chemother 39: 107-111.
31. Tankovic J, Lascols C, Sculo Q, Petit JC, Soussy CJ (2003) Single and double mutations in gyrA but not in gyrB are associated with low- and high-level fluoroquinolone resistance in Helicobacter pylori. Antimicrob Agents Chemother 47: 3942-3944.
32. Hughes NJ, Clayton CL, Chalk PA, Kelly DJ (1998) Helicobacter pylori porCDAB and oorDABC genes encode distinct pyruvate:flavodoxin and 2-oxoglutarate:acceptor oxidoreductases which mediate electron transport to NADP. J Bacteriol 180:
1119-1128.
33. Garcia-Vallve S, Janssen PJ, Ouzounis CA (2002) Genetic variation between Helicobacter pylori strains: gene acquisition or loss? Trends Microbiol 10: 445-447.
34. Testa CA, Lherbet C, Pojer F, Noel JP, Poulter CD (2006) Cloning and expression of IspDF from Mesorhizobium loti. Characterization of a bifunctional protein that catalyzes non-consecutive steps in the methylerythritol phosphate pathway. Biochim Biophys Acta 1764: 85-96.
35. Wolfe AJ (2005) The acetate switch. Microbiol Mol Biol Rev 69: 12-50.
36. Pathak D, Ashley G, Ollis D (1991) Thiol protease-like active site found in the enzyme dienelactone hydrolase: localization using biochemical, genetic, and structural tools.
Proteins 9: 267-279.
37. Bujnicki JM, Oudjama Y, Roovers M, Owczarek S, Caillet J, et al. (2004) Identification of a bifunctional enzyme MnmC involved in the biosynthesis of a hypermodified uridine in the wobble position of tRNA. RNA 10: 1236-1242.
38. Wadhams GH, Armitage JP (2004) Making sense of it all: bacterial chemotaxis. Nat Rev Mol Cell Biol 5: 1024-1037.
39. NRPGM 蛋白質體暨醣質體分析核心設施 In-gel digestion 膠內水解實作
39